alzamend.com - ALZN Forvard narx/daromad multiplikatori
Alzamend Neuro, Inc. (ALZN) kompaniyasining forward P/S tarixi Altsgeymer kasalligi davolash vositalarining jiddiy tanqisligi fonidagi aktivlar dinamikasini aks ettiradi, bunda ko'rsatkichning joriy qiymatini ifodalaydi. Biznes psixiatriyada litiy yetkazib berish bo'yicha yopiq patent perimetriga tayanadi; biroq, daromadlilikning yo'qligi va klinik sinovlarning muvaffaqiyatsiz tugash ehtimoli investorlar uchun sezilarli moliyaviy xatarlarni yuzaga keltirmoqda.
Alzamend Neuro Inc. (ALZN) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- emitentning bozor qiymati haqida ma'lumotlar:
- biznesning balans baholash tafsilotlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Alzamend Neuro, Inc.|ALZN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Alzamend Neuro, Inc.|ALZN - Jamlangan qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Alzamend Neuro|ALZN - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari Alzamend Neuro|Tezkor likvidlik koeffitsiyenti alzamend.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ALZN - Sof moliyaviy natija|Kutilayotgan foyda Alzamend Neuro, Inc.|ALZN - Narx-foyda multiplikatori|Forvard P/E multiplikatori Alzamend Neuro, Inc.|ALZN - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Alzamend|ALZN - Amortizatsiya chegirilmasdan oldingi operatsion daromad|Bir aksiya uchun sof foyda (EPS TTM) Alzamend Neuro|ALZN - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi alzamend.com|ALZN - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Alzamend Neuro, Inc.
- sotuvlar va tushum ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:ALZN (Alzamend)
Alzamend Neuro, Inc. (ALZN) kompaniyasining bozor pasayishlariga chidamliligini baholashda, Altsgeymer terapiyasi bohasida yetakchilik uchun sog'liqni saqlash gigantlari bilan raqobatlashish risklarini hisobga olish juda muhimdir. Kutilayotgan daromadning sotuvga nisbatdagi narx koeffitsiyenti (price-to-sales ratio) prognozini tahlil qilish orqali investor kutilayotgan daromad birligining bozor qiymatini aniqlaydi va olomonning hissiy cho'qqilarini qayd etadi, biroq u qisqa muddatli spekulyativ tebranishlarni haqiqiy fundamental biznes rivojlanish tendentsiyalaridan ajratishi lozim.
Raqobatchilar tahlili
Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Narxning prognoz qilingan daromadga nisbati|AVXL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CeriBell|Forvard P/S multiplikatori Prothena Corporation plc|Narxning prognoz qilingan daromadga nisbati Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati omeros.com OMER|neurogene.com (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|acimmune.com - Forvard P/S multiplikatori|Voyager Therapeutics Inc (VYGR) - Forvard narx/daromad multiplikatori|Neumora Corp (NMRA) - Narxning prognoz qilingan daromadga nisbati|Scilex Holding Company, Inc. (SCLX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TVGN|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alpha Cognition Inc. ACOG|Narxning prognoz qilingan daromadga nisbati cogrx.com (CGTX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Inhibikase Therapeutics, Inc.|Forvard P/S multiplikatori SAVA (Cassava Sciences Inc)|Forvard P/S multiplikatori Assertio Holdings, Inc. ASRT|COYA - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati Vistagen (VTGN)|OVID: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Acumen Pharmaceuticals Inc. (ABOS)|Forvard narx/daromad multiplikatori CRVO|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ATHE (Alterity Therapeutics)|Narxning prognoz qilingan daromadga nisbati Clene Nanomedicine (CLNN)|PEPG (PepGen) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|Sotuvga nisbatan forvard narx RLMD|ANVS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grace Therapeutics Inc|AIFF: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Klotho Neurosciences Inc (KLTO)|Narxning prognoz qilingan daromadga nisbati neurosense-tx.com|Bozor kapitallashuvining kelajakdagi daromadga nisbati Reviva Pharmaceuticals Holdings Inc. RVPH|Narxning prognoz qilingan daromadga nisbati MetaVia Inc. (MTVA)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati NeurAxis Inc|Forvard P/S multiplikatori HSDT (heliusmedical.com)|Sotuvga nisbatan forvard narx PASG|NEUP: Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Minerva Neurosciences Inc|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|Addex Therapeutics, Ltd. - Sotuvga nisbatan forvard narx|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|PTIX (Protagenic Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori
